BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on Protopic® (tacrolimus): Recommendations for the correct use

Active substance: tacrolimus

Important recommendations for the correct use of Protopic® (0.03% and 0.1%) Ointment in order to minimise risks, especially when treating children.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 625KB, File is accessible